Growing community of inventors

Cary, NC, United States of America

David Renwick Houck

Average Co-Inventor Count = 1.54

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 43

David Renwick HouckAndrew Scribner (2 patents)David Renwick HouckKeqiang Li (2 patents)David Renwick HouckHans Georg Fliri (2 patents)David Renwick HouckCyprian Okwara Ogbu (1 patent)David Renwick HouckMichael Robert Peel (1 patent)David Renwick HouckMohsen Arghavani (1 patent)David Renwick HouckDavid Renwick Houck (8 patents)Andrew ScribnerAndrew Scribner (12 patents)Keqiang LiKeqiang Li (5 patents)Hans Georg FliriHans Georg Fliri (2 patents)Cyprian Okwara OgbuCyprian Okwara Ogbu (13 patents)Michael Robert PeelMichael Robert Peel (8 patents)Mohsen ArghavaniMohsen Arghavani (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Scynexis, Inc. (8 from 18 patents)

2. Naurex, Inc. (4 patents)


8 patents:

1. 8551952 - Methods for the treatment and prevention of ocular disorders

2. 8536114 - Macrocycles

3. 8329658 - Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection

4. 8188052 - Method for the treatment and prevention of ocular disorders

5. 7754685 - Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection

6. 7718767 - 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection

7. 7576057 - Cyclic peptides

8. 7196161 - 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…